Cartesian Therapeutics Is A Clinical Stage Biotechnology Company Focused On Developing Mrna Cell Therapies For Autoimmune Diseasesoncologic Disordersand Respiratory Conditionsfounded In 2016The Company Utilizes Its Proprietary Mrna Platform To Engineer Cells Without Integrating Vectorswhich Aims To Enhance Safety And Predictability In Treatment Outcomescartesian Operates A Cgmp Manufacturing Facility In Gaithersburgmarylandallowing For In House Production Of Its Investigational Therapies The Company S Pipeline Includes Innovative Mrna Engineered Chimeric Antigen Receptor T Cellcar Ttherapiesnotable Products Include Descartes 08Targeting Autoimmune Conditions Like Myasthenia Gravis And Systemic Lupus Erythematosusand Descartes 15Aimed At Multiple Myelomaboth Therapies Are Designed To Avoid Preconditioning Chemotherapy And Facilitate Outpatient Administrationcartesian S Collaborationssuch As With The University Of Marylandfurther Support Its Mission To Improve Treatment Accessibility For Patients With Chronic Conditions
